Anas Barbariae Pellet
NDC Package 66096-784-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Anas Barbariae pellets is a human otc drug administered via oral route. This formulation utilizes a pellet delivery system. Marketed by Ohm Pharma Inc., this product is identified by NDC 66096-784.

Identification & Billing

NDC Package Code
66096-784-01
Package Description
6 [hp_C] in 1 TUBE
Product Code
66096-784
11-Digit Billing Format
66096078401

Clinical Specifications

Proprietary Name
Anas Barbariae
Non-Proprietary Name
Anas Barbariae
Substance Name
Cairina Moschata Heart/liver Autolysate
Dosage Form
Pellet - A small sterile solid mass consisting of a highly purified drug (with or without excipients) made by the formation of granules, or by compression and molding.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
CAIRINA MOSCHATA HEART/LIVER AUTOLYSATE 6 [hp_C]/6[hp_C]

Regulatory & Marketing

Labeler Name
Ohm Pharma Inc.
Product Type
Human Otc Drug
Marketing Category
UNAPPROVED HOMEOPATHIC - A category specifying that a product is marketed as unapproved homeopathic product.
Start Marketing Date
11-01-2019
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 66096-784-01 identifies a specific commercial package of 6 [hp_c] in 1 tube of Anas Barbariae, a human over the counter drug labeled by Ohm Pharma Inc.. This pellet is formulated for oral use and contains cairina moschata heart/liver autolysate as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Ohm Pharma Inc. on November 01, 2019. The current certification is valid through December 31, 2026.

How is this Ohm Pharma Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 66096078401. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
66096-784-01
11-Digit CMS (5-4-2)
66096-0784-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.